“Real World Baseline Characteristics and Early Patient Reported Outcomes in Adult Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s145. Accessed May 15, 2026. https://skin.dermsquared.com/skin/article/view/2030.